MILAN — Seladelpar, an investigational selective peroxisome proliferator-activated receptor delta agonist, achieves both biochemical and clinically meaningful improvements in pruritus and liver injury in patients with […]

Novel, noninvasive testing is able to predict dementia onset with 80% accuracy up to 9 years before clinical diagnosis. The results suggest resting-state functional MRI (rs-fMRI) […]

HOUSTON, Texas — Obstructive sleep apnea (OSA) not only affects the patient’s health but also disrupts their partner’s sleep, which can put strain on a relationship.  […]

June 10, 2024 — Prostate cancer has a huge impact on men. It’s the second most common cancer after skin cancer (an estimated 290,00 cases will […]

Is it appropriate to enroll children and adolescents in end-of-life clinical studies? Experts discussed this challenging topic at the 2024 annual congress of the European Society […]

LISBON — The diabetes and weight-loss drug semaglutide improves heart failure–related symptoms and physical limitations regardless of diuretic use in patients with obesity-related heart failure and […]

MILAN — Tirzepatide, a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist, was more effective than placebo was in the resolution of metabolic […]

An 11-member advisory panel to the US Food and Drug Administration (FDA) has unanimously concluded that the investigational anti-amyloid donanemab is effective for the treatment of […]